Biodesix, Inc. (NASDAQ: BDSX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $2.80 price target on the stock.
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management [Yahoo! Finance]